Kewaunee Cost Of Revenue vs Other Operating Expenses Analysis

KEQU Stock

USD 42.69 0.58 1.38%

Kewaunee Scientific financial indicator trend analysis is infinitely more than just investigating Kewaunee Scientific recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kewaunee Scientific is a good investment. Please check the relationship between Kewaunee Scientific Cost Of Revenue and its Other Operating Expenses accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kewaunee Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

For more information on how to buy Kewaunee Stock please use our How to Invest in Kewaunee Scientific guide.

Cost Of Revenue vs Other Operating Expenses

Cost Of Revenue vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Kewaunee Scientific Cost Of Revenue account and Other Operating Expenses. At this time, the significance of the direction appears to have totally related.

The correlation between Kewaunee Scientific's Cost Of Revenue and Other Operating Expenses is 1.0. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Kewaunee Scientific, assuming nothing else is changed. The correlation between historical values of Kewaunee Scientific's Cost Of Revenue and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Kewaunee Scientific are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Cost Of Revenue i.e., Kewaunee Scientific's Cost Of Revenue and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

1.0

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Kewaunee Scientific income statement and represents the costs associated with goods and services Kewaunee Scientific provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Kewaunee Scientific. It is also known as Kewaunee Scientific overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most indicators from Kewaunee Scientific's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kewaunee Scientific current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kewaunee Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

For more information on how to buy Kewaunee Stock please use our How to Invest in Kewaunee Scientific guide.At this time, Kewaunee Scientific's Selling General Administrative is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 9.91 in 2024, despite the fact that Tax Provision is likely to grow to (5.6 M).

	2021	2022	2023	2024 (projected)
Gross Profit	24.2M	35.6M	52.1M	54.7M
Total Revenue	168.9M	219.5M	203.8M	109.6M

Gross Profit Total Revenue

Kewaunee Scientific fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Property Plant And Equipment Gross	Other Liab	Other Assets	Common Stock Total Equity
Total Assets		0.14	0.25	0.7	0.4	0.52	-0.38	0.17	0.71	0.63	0.36	0.71	0.7	0.91	0.87	0.92	0.84	0.44	0.96	0.99	0.09	0.96	0.83	-0.27	0.16	0.84
Short Long Term Debt Total	0.14		0.25	0.4	0.05	0.79	0.67	-0.05	-0.2	0.61	-0.07	-0.2	0.2	0.2	0.16	0.09	0.49	0.2	0.22	0.06	0.48	0.18	0.1	-0.18	-0.54	0.15
Other Current Liab	0.25	0.25		0.37	0.18	0.59	0.18	-0.12	0.07	0.48	-0.26	0.07	0.38	0.35	0.38	0.19	0.44	0.76	0.33	0.24	-0.38	0.35	0.15	-0.81	-0.52	0.36
Total Current Liabilities	0.7	0.4	0.37		0.65	0.68	0.06	0.44	0.2	0.79	0.41	0.2	0.95	0.78	0.56	0.82	0.72	0.18	0.72	0.73	0.38	0.8	0.31	-0.18	0.08	0.59
Total Stockholder Equity	0.4	0.05	0.18	0.65		0.27	-0.33	0.93	0.39	0.55	0.34	0.39	0.53	0.65	0.04	0.46	0.16	-0.1	0.24	0.43	0.4	0.36	0.26	0.09	0.37	0.64
Property Plant And Equipment Net	0.52	0.79	0.59	0.68	0.27		0.41	0.04	0.06	0.89	0.03	0.06	0.58	0.58	0.58	0.47	0.79	0.48	0.61	0.46	0.11	0.57	0.37	-0.38	-0.48	0.52
Net Debt	-0.38	0.67	0.18	0.06	-0.33	0.41		-0.33	-0.83	0.09	-0.3	-0.83	0.01	-0.32	-0.19	-0.23	0.07	0.08	-0.21	-0.4	0.18	-0.19	-0.56	-0.04	-0.61	-0.51
Retained Earnings	0.17	-0.05	-0.12	0.44	0.93	0.04	-0.33		0.26	0.36	0.42	0.26	0.32	0.41	-0.2	0.26	-0.12	-0.41	-0.01	0.19	0.48	0.09	0.11	0.42	0.51	0.44
Cash	0.71	-0.2	0.07	0.2	0.39	0.06	-0.83	0.26		0.28	0.22	1.0	0.15	0.65	0.49	0.47	0.37	0.29	0.55	0.68	-0.01	0.51	0.88	-0.23	0.31	0.81
Non Current Assets Total	0.63	0.61	0.48	0.79	0.55	0.89	0.09	0.36	0.28		0.35	0.28	0.7	0.71	0.61	0.58	0.72	0.24	0.66	0.59	0.18	0.63	0.52	-0.2	-0.1	0.74
Non Currrent Assets Other	0.36	-0.07	-0.26	0.41	0.34	0.03	-0.3	0.42	0.22	0.35		0.22	0.45	0.29	0.3	0.43	0.18	-0.45	0.34	0.39	0.32	0.33	0.25	0.48	0.64	0.31
Cash And Short Term Investments	0.71	-0.2	0.07	0.2	0.39	0.06	-0.83	0.26	1.0	0.28	0.22		0.15	0.65	0.49	0.47	0.37	0.29	0.55	0.68	-0.01	0.51	0.88	-0.23	0.31	0.81
Net Receivables	0.7	0.2	0.38	0.95	0.53	0.58	0.01	0.32	0.15	0.7	0.45	0.15		0.72	0.66	0.85	0.7	0.18	0.76	0.75	0.17	0.83	0.27	-0.18	0.15	0.52
Common Stock Shares Outstanding	0.91	0.2	0.35	0.78	0.65	0.58	-0.32	0.41	0.65	0.71	0.29	0.65	0.72		0.71	0.88	0.79	0.45	0.84	0.91	0.18	0.87	0.7	-0.28	0.16	0.84
Non Current Liabilities Total	0.87	0.16	0.38	0.56	0.04	0.58	-0.19	-0.2	0.49	0.61	0.3	0.49	0.66	0.71		0.77	0.89	0.52	0.95	0.85	-0.22	0.88	0.72	-0.39	-0.03	0.65
Inventory	0.92	0.09	0.19	0.82	0.46	0.47	-0.23	0.26	0.47	0.58	0.43	0.47	0.85	0.88	0.77		0.79	0.31	0.91	0.95	0.19	0.96	0.58	-0.14	0.24	0.67
Other Current Assets	0.84	0.49	0.44	0.72	0.16	0.79	0.07	-0.12	0.37	0.72	0.18	0.37	0.7	0.79	0.89	0.79		0.6	0.92	0.82	0.07	0.88	0.6	-0.46	-0.23	0.61
Other Stockholder Equity	0.44	0.2	0.76	0.18	-0.1	0.48	0.08	-0.41	0.29	0.24	-0.45	0.29	0.18	0.45	0.52	0.31	0.6		0.49	0.41	-0.4	0.47	0.37	-0.83	-0.51	0.34
Total Liab	0.96	0.22	0.33	0.72	0.24	0.61	-0.21	-0.01	0.55	0.66	0.34	0.55	0.76	0.84	0.95	0.91	0.92	0.49		0.96	0.0	0.97	0.74	-0.34	0.04	0.73
Total Current Assets	0.99	0.06	0.24	0.73	0.43	0.46	-0.4	0.19	0.68	0.59	0.39	0.68	0.75	0.91	0.85	0.95	0.82	0.41	0.96		0.09	0.97	0.77	-0.27	0.22	0.8
Short Term Debt	0.09	0.48	-0.38	0.38	0.4	0.11	0.18	0.48	-0.01	0.18	0.32	-0.01	0.17	0.18	-0.22	0.19	0.07	-0.4	0.0	0.09		0.08	-0.03	0.34	0.15	0.07
Accounts Payable	0.96	0.18	0.35	0.8	0.36	0.57	-0.19	0.09	0.51	0.63	0.33	0.51	0.83	0.87	0.88	0.96	0.88	0.47	0.97	0.97	0.08		0.67	-0.33	0.07	0.72
Property Plant And Equipment Gross	0.83	0.1	0.15	0.31	0.26	0.37	-0.56	0.11	0.88	0.52	0.25	0.88	0.27	0.7	0.72	0.58	0.6	0.37	0.74	0.77	-0.03	0.67		-0.23	0.1	0.88
Other Liab	-0.27	-0.18	-0.81	-0.18	0.09	-0.38	-0.04	0.42	-0.23	-0.2	0.48	-0.23	-0.18	-0.28	-0.39	-0.14	-0.46	-0.83	-0.34	-0.27	0.34	-0.33	-0.23		0.57	-0.27
Other Assets	0.16	-0.54	-0.52	0.08	0.37	-0.48	-0.61	0.51	0.31	-0.1	0.64	0.31	0.15	0.16	-0.03	0.24	-0.23	-0.51	0.04	0.22	0.15	0.07	0.1	0.57		0.15
Common Stock Total Equity	0.84	0.15	0.36	0.59	0.64	0.52	-0.51	0.44	0.81	0.74	0.31	0.81	0.52	0.84	0.65	0.67	0.61	0.34	0.73	0.8	0.07	0.72	0.88	-0.27	0.15

Click cells to compare fundamentals

Kewaunee Scientific Account Relationship Matchups

Kewaunee Scientific fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	83.9M	89.4M	118.8M	118.9M	134.8M	141.5M
Short Long Term Debt Total	13.8M	16.1M	9.4M	12.9M	11.0M	8.1M
Other Current Liab	5.4M	6.1M	7.8M	6.7M	7.8M	4.2M
Total Current Liabilities	27.1M	34.2M	42.3M	40.1M	40.8M	20.6M
Total Stockholder Equity	38.4M	41.2M	35.7M	37.4M	54.8M	30.7M
Property Plant And Equipment Net	25.6M	25.3M	22.7M	25.6M	25.1M	16.3M
Net Debt	9.4M	10.9M	5.0M	4.8M	(12.3M)	(11.7M)
Retained Earnings	37.8M	34.1M	28.0M	28.8M	47.5M	25.5M
Cash	4.4M	5.2M	4.4M	8.1M	23.3M	24.4M
Non Current Assets Total	29.7M	28.9M	27.2M	31.0M	37.9M	20.7M
Non Currrent Assets Other	3.8M	2.4M	4.1M	4.5M	5.4M	3.6M
Cash And Short Term Investments	4.4M	5.2M	4.4M	8.1M	23.3M	24.4M
Net Receivables	28.1M	32.9M	54.7M	46.1M	45.1M	25.3M
Common Stock Shares Outstanding	2.8M	2.8M	2.8M	2.9M	2.9M	2.9M
Liabilities And Stockholders Equity	83.9M	89.4M	118.8M	118.9M	134.8M	141.5M
Non Current Liabilities Total	18.2M	13.7M	40.3M	40.4M	37.8M	39.7M
Inventory	15.3M	16.5M	23.8M	21.9M	20.7M	21.7M
Other Current Assets	5.6M	5.9M	8.6M	11.9M	7.8M	8.2M
Other Stockholder Equity	3.3M	3.8M	4.4M	5.0M	3.4M	5.3M
Total Liab	45.2M	47.9M	82.6M	80.4M	78.6M	82.5M
Total Current Assets	54.2M	60.5M	91.6M	87.9M	96.8M	101.7M
Short Term Debt	6.0M	8.2M	3.6M	5.6M	5.3M	4.4M
Accounts Payable	13.1M	16.8M	27.3M	23.6M	23.3M	24.4M
Property Plant And Equipment Gross	25.6M	25.3M	22.7M	25.6M	71.7M	75.3M
Accumulated Other Comprehensive Income	(9.6M)	(3.6M)	(3.7M)	(3.4M)	(3.4M)	(3.6M)
Other Liab	10.3M	5.8M	5.1M	4.9M	5.7M	6.2M
Other Assets	4.1M	3.7M	4.5M	5.4M	6.2M	5.8M
Common Stock Total Equity	6.8M	6.9M	6.9M	6.9M	8.0M	7.3M
Common Stock	6.9M	6.9M	7.0M	7.1M	7.3M	7.4M
Property Plant Equipment	16.3M	25.3M	22.7M	25.6M	29.4M	16.4M
Current Deferred Revenue	2.5M	3.1M	3.5M	4.1M	4.4M	4.6M
Net Tangible Assets	38.4M	41.2M	35.7M	37.4M	43.0M	42.0M
Noncontrolling Interest In Consolidated Entity	462K	603K	288K	246K	221.4K	210.3K
Retained Earnings Total Equity	43.2M	43.6M	37.8M	34.1M	39.3M	35.8M
Capital Surpluse	3.0M	3.1M	3.4M	3.8M	4.4M	2.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Kewaunee Stock Analysis

When running Kewaunee Scientific's price analysis, check to measure Kewaunee Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kewaunee Scientific is operating at the current time. Most of Kewaunee Scientific's value examination focuses on studying past and present price action to predict the probability of Kewaunee Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kewaunee Scientific's price. Additionally, you may evaluate how the addition of Kewaunee Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC